Mansour Alsaleem

1.1k total citations
32 papers, 526 citations indexed

About

Mansour Alsaleem is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mansour Alsaleem has authored 32 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Mansour Alsaleem's work include Breast Cancer Treatment Studies (9 papers), Cancer Genomics and Diagnostics (6 papers) and Estrogen and related hormone effects (5 papers). Mansour Alsaleem is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Genomics and Diagnostics (6 papers) and Estrogen and related hormone effects (5 papers). Mansour Alsaleem collaborates with scholars based in United Kingdom, United States and Saudi Arabia. Mansour Alsaleem's co-authors include Emad A. Rakha, Nigel P. Mongan, Andrew R. Green, Chitra Joseph, Michael S. Toss, Mohammed A. Aleskandarany, Ian O. Ellis, Sasagu Kurozumi, Maryam Althobiti and Islam M. Miligy and has published in prestigious journals such as Molecular and Cellular Biology, Oncogene and Scientific Reports.

In The Last Decade

Mansour Alsaleem

31 papers receiving 523 citations

Peers

Countries citing papers authored by Mansour Alsaleem

Since Specialization

Citations

This map shows the geographic impact of Mansour Alsaleem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mansour Alsaleem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mansour Alsaleem more than expected).

Fields of papers citing papers by Mansour Alsaleem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mansour Alsaleem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mansour Alsaleem. The network helps show where Mansour Alsaleem may publish in the future.

Co-authorship network of co-authors of Mansour Alsaleem

This figure shows the co-authorship network connecting the top 25 collaborators of Mansour Alsaleem. A scholar is included among the top collaborators of Mansour Alsaleem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mansour Alsaleem. Mansour Alsaleem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiotoxicity of breast cancer drug treatments 2025 ·Translational Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mansour Alsaleem, Emad A. Rakha, Sheeba Irshad, Melissa B. Davis, Jennie N. Jeyapalan, Nigel P. Mongan, Catrin S. Rutland	2
2	Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery 2025 ·Journal of Cellular and Molecular Medicine ·Mansour Alsaleem, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Maha M. Abdel‐Fattah, Mohammed Alrouji, (unknown), Mubarak Alruwaili, Marios Papadakis, Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha	2
3	The role of the ALKBH5 RNA demethylase in invasive breast cancer 2024 ·Discover Oncology ·(unknown), Mansour Alsaleem, Michael S. Toss, (unknown), (unknown), Jennie N. Jeyapalan, Nataliya L. Blatt, Albert A. Rizvanov, Regina Miftakhova, (unknown), Srinivasan Madhusudan, Andrew R. Green, Catrin S. Rutland, Rupert G. Fray, Emad A. Rakha, Nigel P. Mongan	1
4	Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena 2024 ·Cellular and Molecular Neurobiology ·Mansour Alsaleem, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, Mohammed Alrouji, (unknown), Αθανάσιος Αλεξίου, Marios Papadakis, Gaber El‐Saber Batiha	2
5	Exosomal MicroRNAs in Alzheimer’s Disease: Unveiling Their Role and Pioneering Tools for Diagnosis and Treatment 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Sultan H. Alamri, Heba Alkhatabi, (unknown), Mansour Alsaleem, Sameh A. Abdelnour, Sabah M. Hassan	7
6	Cell division cycle 6 is an independent prognostic biomarker in breast cancer 2024 ·Pathology ·(unknown), Mansour Alsaleem, (unknown), Bader Y. Alhatlani, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha	0
7	The Conflicting Prognostic Role of the Stroma–Tumor Ratio in Breast Cancer Molecular Subtypes 2024 ·Modern Pathology ·(unknown), (unknown), Mansour Alsaleem, Catrin S. Rutland, Cinzia Allegrucci, Nigel P. Mongan, (unknown)	1
8	Novel 2 Gene Signatures Associated With Breast Cancer Proliferation: Insights From Predictive Differential Gene Expression Analysis 2023 ·Modern Pathology ·Asmaa Ibrahim, Michael S. Toss, Mansour Alsaleem, (unknown), (unknown), Andrew R. Green, Emad A. Rakha	4
9	Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level 2023 ·British Journal of Cancer ·(unknown), Mansour Alsaleem, Michael S. Toss, Nigel P. Mongan, Emad A. Rakha	14
10	Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance 2023 ·European Journal of Cancer ·(unknown), Cecily Quinn, Michael S. Toss, Mansour Alsaleem, (unknown), Asmaa Ibrahim, Catrin S. Rutland, Nigel P. Mongan, Emad A. Rakha	6
11	Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression 2023 ·European Journal of Cancer ·(unknown), (unknown), Cecily Quinn, Michael S. Toss, (unknown), Asmaa Ibrahim, Andrew R. Green, Mansour Alsaleem, Catrin S. Rutland, Cinzia Allegrucci, Nigel P. Mongan, Emad A. Rakha	15
12	Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis 2021 ·Molecular Cancer Research ·Sameer Mirza, (unknown), Mohsin Ali Raza, (unknown), Bhopal Mohapatra, (unknown), Michel M. Ouellette, Fang Qiu, Lulu Yu, Alexei Lobanov, Zhi‐Ming Zheng, Ying Zhang, Mansour Alsaleem, Emad A. Rakha, Hamid Band, M. Jordan Rowley, Vimla Band	6
13	Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers 2021 ·Oncogene ·Reem Ali, (unknown), Islam M. Miligy, (unknown), Mansour Alsaleem, Michael S. Toss, (unknown), Tarek M. Abdel-Fatah, Paul M. Moseley, Stephen Chan, Nigel P. Mongan, Satya Narayan, Emad A. Rakha, Srinivasan Madhusudan	21
14	Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets 2020 ·Breast Cancer Research ·Sasagu Kurozumi, Mansour Alsaleem, (unknown), (unknown), Stacey E. P. Joosten, Takaaki Fujii, Ken Shirabe, Andrew R. Green, Ian O. Ellis, Emad A. Rakha, Nigel P. Mongan, David M. Heery, Wilbert Zwart, Steffi Oesterreich, Simon J. Johnston	33
15	Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers 2020 ·Scientific Reports ·Angela Ogden, Shristi Bhattarai, (unknown), Nigel P. Mongan, Mansour Alsaleem, Andrew R. Green, Mohammed A. Aleskandarany, Ian O. Ellis, (unknown), Xiaoxian Li, Carlos S. Moreno, Uma Krishnamurti, Emiel A. M. Janssen, Kristín Jónsdóttir, Emad A. Rakha, Padmashree C.G. Rida, Ritu Aneja	38
16	The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer 2020 ·Breast Cancer Research and Treatment ·(unknown), Mansour Alsaleem, Chitra Joseph, (unknown), (unknown), Sho Shiino, (unknown), Michael S. Toss, Andrew R. Green, Emad A. Rakha	27
17	Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer 2019 ·British Journal of Cancer ·Chitra Joseph, (unknown), Mansour Alsaleem, Sasagu Kurozumi, Michael S. Toss, (unknown), (unknown), (unknown), Mohammed A. Aleskandarany, Simak Ali, Ian O. Ellis, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha	18
18	Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer 2019 ·Breast Cancer Research and Treatment ·(unknown), Chitra Joseph, Sasagu Kurozumi, Michael S. Toss, Mansour Alsaleem, (unknown), Nigel P. Mongan, Mohammed A. Aleskandarany, Andrew R. Green, Emad A. Rakha	20
19	The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts 2019 ·Modern Pathology ·Mansour Alsaleem, Michael S. Toss, Chitra Joseph, Mohammed A. Aleskandarany, Sasagu Kurozumi, (unknown), Angela Ogden, Padmashree C.G. Rida, Ian O. Ellis, Ritu Aneja, Andrew R. Green, Nigel P. Mongan, Emad A. Rakha	33
20	Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer 2019 ·Breast Cancer Research and Treatment ·Sasagu Kurozumi, Chitra Joseph, (unknown), (unknown), (unknown), (unknown), (unknown), Mansour Alsaleem, Christopher C. Nolan, Simon J. Johnston, Mohammed A. Aleskandarany, Angela Ogden, Takaaki Fujii, Ken Shirabe, Stewart G. Martin, (unknown), Nigel P. Mongan, Ian O. Ellis, Andrew R. Green, Emad A. Rakha	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact